IRUBIS

📍 Munich, Germany🗓 Founded 2017👥 21 employees💰 Last funded Sep 2025
Biotechnology Research🌐 irubis.com
Website LinkedIn
IRUBIS | Innovative Process Analytical Spectroscopy for Biomanufacturing. IRUBIS develops advanced Process Analytical Technology (PAT) tool based on mid-infrared (MIR) spectroscopy to bring intelligence to biopharmaceutical manufacturing. Its flagship product, Monipa, with single-use capabilities delivers inline, real-time concentration data for proteins, excipients, and nucleic acids—empowering faster decision-making, reducing batch loss, and simplifying bioprocess development and scale-up. Read more about our products and innovations at www.irubis.com.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in IRUBIS?
IRUBIS has 1 investors on record on gritt.io and 1 late-stage investors.
When did IRUBIS last raise funding?
The most recent investment in IRUBIS recorded on gritt.io was in September 2025.
When was IRUBIS founded?
IRUBIS was founded in 2017.
What industry is IRUBIS in?
IRUBIS operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is IRUBIS based?
IRUBIS is headquartered in Munich, Germany.